Skip to main content
New Rewards! ¡Nuevas recompensas!

Our Healthy Rewards Program is getting an update in September! For a sneak peek of all the changes - including new rewards and ways to redeem them - please click here.

¡Nuestro Programa Healthy Rewards tendrá su actualización en septiembre! Para ver un adelanto de todos los cambios, incluyendo nuevas recompensas y formas de canjearlas, haz clic aquí.

2025–26 RSV Season and Synagis Prior Authorization for All State Health Service Regions

Date: September 23, 2025

Attention: All Providers

Subject: 2025–26 RSV Season and Synagis Prior Authorization for All State Health Service Regions

Effective Date: October 1, 2025

Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective October 1, 2025, the Texas Health and Human Services (HHSC) will open all counties in State Health Service to Palivizumab (Synagis) prophylaxis for 2025-26 Fall/Winter Respiratory Syncytial Virus (RSV) season. Refer to the season schedule for each region's start and end dates.

How this impacts providers: HHSC will accept fee-for-service (FFS) prior authorization requests by fax and as early as September 22, 2025.

Prescribing providers must prescribe Synagis to infants meeting the criteria as described on the American Academy of Pediatrics website

Drug NameStrengthNDC
Synagis100 MG/1 ml Vial66658023101
Synagis50 MG/0.5 ml Vial66658023001
  • Pharmacy Benefit Access

Similar to STAR and STAR KIDS, Synagis for CHIP members will be available through the pharmacy benefit. Prior authorization (PA) criteria will be the same for all members.

  • Initial PA Request Required

Providers must submit a new PA request for all members who meet criteria for RSV prophylaxis. Only one initial request is needed per treatment course (up to five doses).

  • Dose Approval Details

Approvals will be granted for one monthly dose at a time, with a 10-day window for pharmacy adjudication. Providers should retain Synagis vials until administration to avoid missed doses.

  • Required Forms for PA Submission

Providers must submit both the Texas Department of Insurance (TDI) Synagis PA Form and the TCHP Standard PA Request Form.

  • Forms are available on the Navitus page.
  • Texas HHSC has also created the Synagis Standard PA Addendum (HHS Form 1321) to accompany the TDI form.
  • No Refill PA Required

Pharmacies are not required to submit refill PA requests for subsequent doses.

  • Hospitalization Note

Members hospitalized for RSV during the season may be denied further Synagis refills.

  • Preferred Pharmacies

Acaria Health Pharmacy and Lumicera Specialty Pharmacy are the preferred options for all providers.

2025-26 Synagis Prior Authorization Schedule:

Updated as of September 11, 2025. Refer to HHSC’s website for the most up-to-date information.

Providers can find their region using theinteractive region map (PDF)and selecting the buttons marked HHS regions and county names.

Table 1: Region Dates

RegionStart DateEnd Date
1 - High PlainsNov. 15, 2025April 17, 2026
2 - Northwest TexasNov. 15, 2025April 17, 2026
3 - MetroplexNov. 1, 2025March 31, 2026
4 - Upper East TexasNov. 1, 2025March 31, 2026
5 - Southeast TexasOct. 1, 2025Feb. 28, 2026
6 - Gulf CoastOct. 1, 2025Feb. 28, 2026
7 - Central TexasOct. 15, 2025March 13, 2026
8 - Upper South TexasNov. 1, 2025March 31, 2025
9 - West TexasNov. 15, 2025April 17, 2026
10 - Upper Rio GrandeNov. 15, 2025April 17, 2026
11 - Lower South TexasOct. 15, 2025March 31, 2026

 

Next steps for providers: Refer to the 2025-2026 RSV season schedule for information regarding start and end dates for all regions. Providers should continue to follow American Academy of Pediatrics guidelines when prescribing and should share this communication with their staff.

Resources:

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts,log into
www.texaschildrenshealthplan.org/provideralerts.